European Esoteric Testing Market size is poised to cross USD 17.5 billion by 2028, according to a latest forecast report by Graphical Research.
The growing prevalence of rare diseases in the region, including rare cancers, infectious tropical diseases, and degenerative diseases has resulted in the influx of public and private investments for creating effective disease treatment options. The European Union, for instance, is actively funding cross-border research for rare diseases through its Framework Programs for Research and Technological Development. The organization is also taking complementary actions for novel drug development through funding various health programs.
Similarly, the EURORDIS, a non-governmental patient-driven alliance of life-threatening rare diseases, is undertaking efforts to create awareness regarding the ill effects of undiagnosed rare diseases. Rising awareness about early disease diagnosis will aid in the market expansion.
The infectious disease & immunology test type segment held more than 27.5% market share in 2021.
Rare infectious diseases are spreading at an alarming rate across the region. As per the European Union, campylobacteriosis, chlamydia infection, salmonellosis, tuberculosis, and gonorrhea are some of the commonly reported infectious diseases in the EU and EEA. The adoption of advanced technological kits for precise and easy disease diagnosis is positively impacting the demand for suitable esoteric testing solutions in Europe.
The chemiluminescence technology segment will exceed USD 2.5 billion by 2028. It offers high-quality depending on the testing needs. It utilizes low analyte volume and can deliver patient outcomes in lesser time duration. Such features are ideal and beneficial for molecular testing. Other technologies used in esoteric testing include flow cytometry, mass spectrometry, ELISA, chemiluminescence, radioimmunoassay, and RT-PCR.
Browse detailed statistical insights from the report, “Europe Esoteric Testing Market Forecast 2028 By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, RT-PCR), By Test type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics), Research Report, Country Outlook (Germany, UK, France, Italy, Spain, Russia, Poland, Sweden, The Netherlands, Portugal, Denmark, Norway), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
Germany esoteric testing industry size is likely to grow at a steady pace through 2028. One of the key factors driving testing demand in the region is the rising frequency of patients affected with rare diseases. The National Action League for People with Rare Diseases states that nearly 4 million Germans are directly affected by a rare or unique disease in the country.
To serve this growing patient pool, the nation has developed a set of centralized core programs for research, screening, and access to treatment for rare disease management. With growing disease and treatment awareness, alongside the presence of proper infrastructure for the diagnosis of rare ailments.
The European market for esoteric testing research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:
Europe Market, By Test Type
- Infectious Disease & Immunology
Europe Market, By Technology
- Mass Spectrometry
- Flow Cytometry
The above information has been provided for the following countries:
- The Netherlands